Table 5.
Controls* | FCD cases* | Controls no asthma‡ | Controls asthma‡ | |||||
---|---|---|---|---|---|---|---|---|
n = 539 | n = 279 | n = 421 | n = 133 | |||||
Family history | n (%) | n (%) | adj OR† for FCD (95% CI) | P-value | n (%) | n (%) | adj OR§ for asthma (95% CI) | P-value |
Asthma: mother | 75 (14·8) | 36 (13·8) | 0·92 (0·59–1·43) | 0·71 | 49 (12·2) | 30 (25·9) | 2·81 (1·65–4·77) | <0·0001 |
Asthma: father | 51 (10·3) | 26 (10·4) | 0·94 (0·56–1·57) | 0·82 | 31 (8·0) | 21 (18·3) | 2·42 (1·31–4·48) | 0·005 |
Asthma: sibling¶ | 147 (29·8) | 61 (23·9) | 0·77 (0·53–1·12) | 0·17 | 94 (24·4) | 54 (45·0) | 3·02 (1·90–4·79) | <0·0001 |
Hayfever: mother | 145 (30·0) | 73 (28·2) | 0·96 (0·67–1·38) | 0·84 | 106 (27·5) | 41 (37·6) | 1·76 (1·10–2·80) | 0·02 |
Hayfever: father | 90 (19·3) | 44 (18·3) | 0·97 (0·63–1·49) | 0·89 | 57 (15·3) | 33 (31·1) | 2·55 (1·52–4·29) | <0·0001 |
Hayfever: sibling¶ | 207 (43·6) | 95 (37·9) | 0·78 (0·55–1·10) | 0·16 | 151 (40·3) | 62 (55·9) | 2·29 (1·45–3·64) | <0·0001 |
Rheumatoid arthritis** | 84 (17·7) | 40 (16·3) | 0·88 (0·56–1·40) | 0·60 | 64 (17·1) | 23 (20·2) | 1·04 (0·60–1·84) | 0·88 |
Multiple sclerosis** | 5 (1·0) | 11 (4·3) | 4·15 (1·42–12·2) | 0·009 | 4 (1·1) | 2 (1·7) | 2·26 (0·37–13·82) | 0·38 |
Autoimmune thyroiditis** | 20 (4·2) | 9 (3·7) | 0·91 (0·38–2·20) | 0·83 | 16 (4·2) | 4 (3·4) | 0·76 (0·25–2·34) | 0·63 |
Inflammatory bowel disease** | 35 (7·2) | 23 (9·0) | 1·49 (0·84–2·66) | 0·17 | 26 (6·8) | 10 (8·3) | 1·42 (0·65–3·07) | 0·38 |
Matched FCD cases and controls with complete data.
Matched odds ratios adjusted (adjOR) for level of education and ever smoker.
All interviewed controls with allergy data, including those not matched to a participating case.
OR adjusted for age, gender, level of education and ever smoker.
Additionally adjusted for sibship size.
Mother, father and/or sibling had history of disorder. FCD: a first clinical diagnosis of central nervous system demyelination; CI: confidence interval.